Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol.

Mondal B, Chen H, Wen W, Cavalieri EL, Rogan EG, Zahid M.

ACS Omega. 2018 May 31;3(5):5511-5515. doi: 10.1021/acsomega.7b01727. Epub 2018 May 21.

2.

Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.

Cavalieri EL, Rogan EG, Zahid M.

Int J Cancer. 2017 Sep 15;141(6):1078-1090. doi: 10.1002/ijc.30728. Epub 2017 Apr 24. Review.

PMID:
28388839
3.

Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention.

Cavalieri EL, Rogan EG.

Clin Transl Med. 2016 Mar;5(1):12. doi: 10.1186/s40169-016-0088-3. Epub 2016 Mar 15. Review.

4.

Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Warthin Tumor of the Parotid Gland: A Case Report and Literature Review.

Di Napoli A, Mallel G, Bartolazzi A, Cavalieri E, Becelli R, Cippitelli C, Ruco L.

Int J Surg Pathol. 2015 Aug;23(5):419-23. doi: 10.1177/1066896915582263. Review.

PMID:
26169920
5.

Breast health and reducing breast cancer risk: a functional medicine approach.

Muran PJ, Muran SY, Beseler CL, Cavalieri EL, Rogan EG, Zahid M.

J Altern Complement Med. 2015 Jun;21(6):321-6. doi: 10.1089/acm.2014.0365. Epub 2015 May 14.

PMID:
25974761
6.

Associations between Dietary Intake of Fruits and Vegetables in relation to Urinary Estrogen DNA Adduct Ratio.

Reding KW, Zahid M, Cavalieri E, Rogan EG, Raccor BS, Atkinson C, Yong M, Newton KM, Lampe JW.

Open J Prev Med. 2014 Jun;4(6):429-437.

7.

The use of the serratus anterior muscle vascular pedicle as recipient site in DIEP flap transfer for breast reconstruction.

Santanelli di Pompeo F, Longo B, Laporta R, Pagnoni M, Cavalieri E.

J Plast Reconstr Aesthet Surg. 2014 Apr;67(4):456-60. doi: 10.1016/j.bjps.2013.12.033. Epub 2013 Dec 31.

PMID:
24529692
8.

Unbalanced estrogen metabolism in ovarian cancer.

Zahid M, Beseler CL, Hall JB, LeVan T, Cavalieri EL, Rogan EG.

Int J Cancer. 2014 May 15;134(10):2414-23. doi: 10.1002/ijc.28565. Epub 2014 Jan 25.

9.

Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs.

Butturini E, Carcereri de Prati A, Chiavegato G, Rigo A, Cavalieri E, Darra E, Mariotto S.

Free Radic Biol Med. 2013 Dec;65:1322-30. doi: 10.1016/j.freeradbiomed.2013.09.015. Epub 2013 Oct 1.

PMID:
24095958
10.
11.

Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells.

Yang L, Zahid M, Liao Y, Rogan EG, Cavalieri EL, Davidson NE, Yager JD, Visvanathan K, Groopman JD, Kensler TW.

Carcinogenesis. 2013 Nov;34(11):2587-92. doi: 10.1093/carcin/bgt246. Epub 2013 Jul 10.

12.

Unbalanced estrogen metabolism in thyroid cancer.

Zahid M, Goldner W, Beseler CL, Rogan EG, Cavalieri EL.

Int J Cancer. 2013 Dec 1;133(11):2642-9. doi: 10.1002/ijc.28275. Epub 2013 Jun 14.

13.

α-bisabolol is an effective proapoptotic agent against BCR-ABL(+) cells in synergism with Imatinib and Nilotinib.

Bonifacio M, Rigo A, Guardalben E, Bergamini C, Cavalieri E, Fato R, Pizzolo G, Suzuki H, Vinante F.

PLoS One. 2012;7(10):e46674. doi: 10.1371/journal.pone.0046674. Epub 2012 Oct 3.

14.

Quality of life and physicians' perception in myelodysplastic syndromes.

Oliva EN, Finelli C, Santini V, Poloni A, Liso V, Cilloni D, Impera S, Terenzi A, Levis A, Cortelezzi A, Ghio R, Musto P, Semenzato G, Clissa C, Lunghi T, Trappolini S, Gaidano V, Salvi F, Reda G, Villani O, Binotto G, Cufari P, Cavalieri E, Spiriti MA.

Am J Blood Res. 2012;2(2):136-47. Epub 2012 May 25.

15.

Preface.

Cavalieri E, Rogan EG.

Drug Discov Today Dis Mech. 2012 Summer;9(1-2):e1-e3. Epub 2012 Dec 22. No abstract available.

16.

The etiology and prevention of breast cancer.

Cavalieri EL, Rogan EG.

Drug Discov Today Dis Mech. 2012 Summer;9(1-2):e55-e69.

17.

HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questions.

Cox MC, Aloe-Spiriti MA, Cavalieri E, Alma E, Gigante E, Begini P, Rebecchini C, Delle Fave G, Marignani M.

World J Gastrointest Oncol. 2012 Mar 15;4(3):46-53. doi: 10.4251/wjgo.v4.i3.46.

18.

Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma.

De Sanctis V, Filippone FR, Alfò M, Muni R, Cavalieri E, Pulsoni A, Annechini G, Valeriani M, Osti MF, Minniti G, Enrici RM.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):755-61. doi: 10.1016/j.ijrobp.2011.12.066. Epub 2012 Mar 11.

PMID:
22414282
19.

Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk.

Pruthi S, Yang L, Sandhu NP, Ingle JN, Beseler CL, Suman VJ, Cavalieri EL, Rogan EG.

J Steroid Biochem Mol Biol. 2012 Oct;132(1-2):73-9. doi: 10.1016/j.jsbmb.2012.02.002. Epub 2012 Feb 24.

20.

Mechanism of DNA depurination by carcinogens in relation to cancer initiation.

Cavalieri E, Saeed M, Zahid M, Cassada D, Snow D, Miljkovic M, Rogan E.

IUBMB Life. 2012 Feb;64(2):169-79. doi: 10.1002/iub.586. Epub 2011 Dec 9.

21.

Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease.

Zahid M, Saeed M, Yang L, Beseler C, Rogan E, Cavalieri EL.

IUBMB Life. 2011 Dec;63(12):1087-93. doi: 10.1002/iub.538. Epub 2011 Nov 2.

22.

Formation of diethylstilbestrol-DNA adducts in human breast epithelial cells and inhibition by resveratrol.

Hinrichs B, Zahid M, Saeed M, Ali MF, Cavalieri EL, Rogan EG.

J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):276-81. doi: 10.1016/j.jsbmb.2011.08.009. Epub 2011 Aug 26.

23.

Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.

Cox MC, Ambrogi V, Lanni V, Cavalieri E, Pelliccia S, Scopinaro F, Monarca B, Marchetti P, Spiriti MA.

Leuk Lymphoma. 2012 Feb;53(2):263-9. doi: 10.3109/10428194.2011.614704. Epub 2011 Sep 23.

PMID:
21846184
24.

Imbalanced estrogen metabolism in the brain: possible relevance to the etiology of Parkinson's disease.

Gaikwad NW, Murman D, Beseler CL, Zahid M, Rogan EG, Cavalieri EL.

Biomarkers. 2011 Aug;16(5):434-44. doi: 10.3109/1354750X.2011.588725. Epub 2011 Jun 21.

25.

Two naturally occurring terpenes, dehydrocostuslactone and costunolide, decrease intracellular GSH content and inhibit STAT3 activation.

Butturini E, Cavalieri E, de Prati AC, Darra E, Rigo A, Shoji K, Murayama N, Yamazaki H, Watanabe Y, Suzuki H, Mariotto S.

PLoS One. 2011;6(5):e20174. doi: 10.1371/journal.pone.0020174. Epub 2011 May 18.

26.

A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.

Zinzani PL, Tani M, Pulsoni A, De Renzo A, Stefoni V, Broccoli A, Montini GC, Fina M, Pellegrini C, Gandolfi L, Cavalieri E, Torelli F, Scopinaro F, Argnani L, Quirini F, Derenzini E, Rossi M, Pileri S, Fanti S, Baccarani M.

Ann Oncol. 2012 Feb;23(2):415-20. doi: 10.1093/annonc/mdr145. Epub 2011 May 2.

PMID:
21536660
27.

Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells.

Cavalieri E, Rigo A, Bonifacio M, Carcereri de Prati A, Guardalben E, Bergamini C, Fato R, Pizzolo G, Suzuki H, Vinante F.

J Transl Med. 2011 Apr 21;9:45. doi: 10.1186/1479-5876-9-45.

28.

Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.

Cavalieri EL, Rogan EG.

J Steroid Biochem Mol Biol. 2011 Jul;125(3-5):169-80. doi: 10.1016/j.jsbmb.2011.03.008. Epub 2011 Mar 21. Review.

29.

Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland.

Kim T, Park H, Yue W, Wang JP, Atkins KA, Zhang Z, Rogan EG, Cavalieri EL, Mohammad KS, Kim S, Santen RJ, Aiyar SE.

Breast Cancer Res Treat. 2011 Apr;126(3):779-89. doi: 10.1007/s10549-010-1301-5. Epub 2010 Dec 18.

30.

Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?

Cavalieri EL, Rogan EG.

IUBMB Life. 2010 Oct;62(10):746-51. doi: 10.1002/iub.376.

31.

Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells.

Zahid M, Saeed M, Beseler C, Rogan EG, Cavalieri EL.

Free Radic Biol Med. 2011 Jan 1;50(1):78-85. doi: 10.1016/j.freeradbiomed.2010.10.662. Epub 2010 Oct 8.

32.

Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseases.

Ebner FH, Mariotto S, Darra E, Suzuki H, Cavalieri E.

Cent Nerv Syst Agents Med Chem. 2011 Mar 1;11(1):2-7. Review.

PMID:
20812906
33.

Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma.

D'Elia GM, De Angelis F, Breccia M, Annechini G, Panfilio S, Danieli R, Cavalieri E, Pulsoni A.

Leuk Res. 2010 Nov;34(11):e300-1. doi: 10.1016/j.leukres.2010.06.011. Epub 2010 Jul 13. No abstract available.

PMID:
20630589
34.

N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.

Zahid M, Saeed M, Ali MF, Rogan EG, Cavalieri EL.

Free Radic Biol Med. 2010 Aug 1;49(3):392-400. doi: 10.1016/j.freeradbiomed.2010.04.028. Epub 2010 May 31.

35.

Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study.

Tinazzi E, Amelio E, Marangoni E, Guerra C, Puccetti A, Codella OM, Simeoni S, Cavalieri E, Montagnana M, Adani R, Corrocher R, Lunardi C.

Rheumatol Int. 2011 May;31(5):651-6. doi: 10.1007/s00296-009-1339-z. Epub 2010 Jan 12.

PMID:
20066427
36.

Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.

Cavalieri EL, Rogan EG.

Future Oncol. 2010 Jan;6(1):75-91. doi: 10.2217/fon.09.137. Review.

37.

Intrahost and interhost variability of the HIV type 1 nef gene in Brazilian children.

Cavalieri E, Florido C, Leal E, Machado DM, Camargo M, Diaz RS, Janini LM.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1129-40. doi: 10.1089/aid.2009.0061.

PMID:
19943790
38.

Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease.

Zahid M, Saeed M, Rogan EG, Cavalieri EL.

Free Radic Biol Med. 2010 Jan 15;48(2):318-24. doi: 10.1016/j.freeradbiomed.2009.11.002. Epub 2009 Nov 10.

39.

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma.

Gaikwad NW, Yang L, Weisenburger DD, Vose J, Beseler C, Rogan EG, Cavalieri EL.

Biomarkers. 2009 Nov;14(7):502-12. doi: 10.3109/13547500903121715.

40.

Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.

Cavalieri E, Matturro A, Annechini G, De Angelis F, Frattarelli N, Gentilini F, Grapulin L, Sacco M, Torelli F, Vignetti M, Mandelli F, Foà R, Pulsoni A.

Leuk Lymphoma. 2009 Nov;50(11):1803-8. doi: 10.3109/10428190903254383.

PMID:
19860621
41.

NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.

Singh S, Zahid M, Saeed M, Gaikwad NW, Meza JL, Cavalieri EL, Rogan EG, Chakravarti D.

J Steroid Biochem Mol Biol. 2009 Oct;117(1-3):56-66. doi: 10.1016/j.jsbmb.2009.07.003. Epub 2009 Jul 21.

42.

Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation.

Saeed M, Higginbotham S, Gaikwad N, Chakravarti D, Rogan E, Cavalieri E.

Free Radic Biol Med. 2009 Oct 1;47(7):1075-81. doi: 10.1016/j.freeradbiomed.2009.07.020. Epub 2009 Jul 18.

43.

Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory action.

Mariotto S, de Prati AC, Cavalieri E, Amelio E, Marlinghaus E, Suzuki H.

Curr Med Chem. 2009;16(19):2366-72. Review.

PMID:
19601786
44.

Involvement of mitochondrial permeability transition pore opening in alpha-bisabolol induced apoptosis.

Cavalieri E, Bergamini C, Mariotto S, Leoni S, Perbellini L, Darra E, Suzuki H, Fato R, Lenaz G.

FEBS J. 2009 Aug;276(15):3990-4000. doi: 10.1111/j.1742-4658.2009.07108.x. Epub 2009 Jun 29.

45.

Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.

Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W.

Ann N Y Acad Sci. 2009 Feb;1155:132-40. doi: 10.1111/j.1749-6632.2008.03685.x. Review.

PMID:
19250200
46.

Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells.

Lu F, Zahid M, Wang C, Saeed M, Cavalieri EL, Rogan EG.

Cancer Prev Res (Phila). 2008 Jul;1(2):135-45. doi: 10.1158/1940-6207.CAPR-08-0037.

47.

Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/reperfusion-induced injury.

Scarabelli TM, Mariotto S, Abdel-Azeim S, Shoji K, Darra E, Stephanou A, Chen-Scarabelli C, Marechal JD, Knight R, Ciampa A, Saravolatz L, de Prati AC, Yuan Z, Cavalieri E, Menegazzi M, Latchman D, Pizza C, Perahia D, Suzuki H.

FEBS Lett. 2009 Feb 4;583(3):531-41. doi: 10.1016/j.febslet.2008.12.037. Epub 2008 Dec 29.

48.

Urine biomarkers of risk in the molecular etiology of breast cancer.

Gaikwad NW, Yang L, Pruthi S, Ingle JN, Sandhu N, Rogan EG, Cavalieri EL.

Breast Cancer (Auckl). 2009 Jan 6;3:1-8.

49.
50.

Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.

Gaikwad NW, Yang L, Rogan EG, Cavalieri EL.

Free Radic Biol Med. 2009 Jan 15;46(2):253-62. doi: 10.1016/j.freeradbiomed.2008.10.029. Epub 2008 Nov 1.

Supplemental Content

Loading ...
Support Center